Muti-center registry study for stent therapy for renal artery stepsons
Not Applicable
- Conditions
- Atheroscirerotic renal artery stenosis
- Registration Number
- JPRN-UMIN000014225
- Lead Sponsor
- JRAS Resitry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
1, eGFR <10 ml/min 2, renal size <7cm 3, obstructive renal artery 4, severe renal artery calcification 5, branch lesion 6, hematoma or thrombosis 7, hemorrhagic diathesis 8, leakage 9, aneurysm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie renal artery stent efficacy in atherosclerotic renal artery stenosis (ARAS)?
How does renal artery stent therapy compare to medical management for ARAS in terms of long-term renal function preservation?
Which biomarkers correlate with improved blood pressure control after stent placement in ARAS patients?
What are the most common periprocedural complications of renal artery stenting in atherosclerotic disease and their management?
Are drug-eluting stents superior to bare-metal stents for treating atherosclerotic renal artery stenosis in J-RAS Registry?